|
For Immediate Release November 2012, Royal Tunbridge Wells, EPG Health Media has announced the launch of it’s latest interactive educational resource for healthcare professionals - the Prostate Cancer Knowledge Centre. This resource, which has been sponsored by Astellas Pharma Europe Ltd, is designed to provide general practitioners, oncologists, urologists and other healthcare professionals with access to the latest information in the area of prostate cancer. The Knowledge Centre can be accessed via the Oncology, Men’s Health and Internal Medicine sections of EPG Online (www.epgonline.org), a website providing free educational content for healthcare professionals. Over 385,500 new cases of prostate cancer were diagnosed in 2008,[1] making it the most frequently diagnosed cancer in European men, with the exception of skin cancers.[2] Therefore prostate cancer represents a major cause of morbidity, especially in the developed world. The site will provide information on both hormone-sensitive and castrate-resistant prostate cancer, detailing current screening and detection methods, and the recommended treatment options available for individual patients. “Remaining up-to-date with current disease processes and treatments is a crucial requirement and challenge for doctors” stated Chris Cooper, Managing Director, EPG Health Media. “We have been pleased to work with Astellas Pharma Europe Ltd to make this valuable resource freely available to users of EPG Online.” EPG Online, the professional channel for doctors, is an independent website dedicated to providing doctors and other healthcare professionals with current disease and treatment information. Organised within 50 disease topic areas, doctors can find drug data (in 9 European languages), clinical trial study outcomes, guidelines for treatment, news, journal articles, multimedia and other content from reputable sources. ENDS NOTES TO EDITORS ABOUT EPG Online With over 110,000 pages of content, EPG Online represents the largest free disease and medicines website for European doctors. The website is operated by EPG Health Media, a digital health publisher dedicated to providing a quality learning platform for doctors worldwide. For more information about EPG Health Media, please visit www.epghealthmedia.com. ABOUT Astellas Pharma Europe Ltd. Astellas Pharma Europe Ltd., located in the UK, is the European headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. The organisation’s focus is to deliver outstanding R&D and marketing to continue growing in the world pharmaceutical market. Astellas Pharma Europe Ltd. is responsible for 21 affiliate offices located across Europe, the Middle East and Africa, an R&D site and three manufacturing plants. The company employs approximately 4,300 staff across these regions. For more information about Astellas Pharma Europe, please visit www.astellas.eu. References 1. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127(12):2893–2917 2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92. Date of preparation September 2012 EGD/12/0016/EUg Developed by EPG Online in partnership with, and with financial support from, Astellas Pharma Europe Ltd
Related Articles -
prostate, cancer, treatment, management, hormone-sensitive, castration-resistant,
|
